Cuneo, Kyle C.

A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer

Whitley, M. J., Cardona, D. M., Lazarides, A. L., Spasojevic, I., Ferrer, J. M., Cahill, J., Lee, C.-L., Snuderl, M., Blazer, D. G., Hwang, E. S., et al. (2016) · Science Translational Medicine

Protease and Inhibitor MechanismsNanoplatforms for cancer theranostics

Cited by 296

Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib

Cuneo, K. C., Mehta, R. K., Kurapati, H., Thomas, D. G., Lawrence, T. S., & Nyati, M. K. (2019) · Translational Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 38

Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy

Ray, D., Cuneo, K. C., Rehemtulla, A., Lawrence, T. S., & Nyati, M. K. (2015) · Neoplasia

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 22